Inventor

TANG TONY P

US33 patents

⚠️ This page may combine multiple inventors who share the name “TANG TONY P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TANG TONY P

ARRAY BIOPHARMA INC

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Crystalline forms

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Serine/threonine kinase inhibitors

Serine/threonine kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases

5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors

Pyrimidyl cyclopentanes as Akt protein kinase inhibitors

5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors

MIRATI THERAPEUTICS INC

KRas G12C inhibitors

KRAS G12C inhibitors

KRas G12D inhibitors

KRas G12C inhibitors

KRas G12C inhibitors

KRas G12D inhibitors

LOXO ONCOLOGY INC

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile

BANKA ANNA L

5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors